Comparing the efficacy of efgartigimod and intravenous immunoglobulin on AQP4‐IgG‐positive neuromyelitis optica spectrum disorder during acute attacks

Documenti analoghi

• Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies
  di: Iek Leng Cheng, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction
  di: Tamara Szabados, et al.
  Pubblicazione: (2024)
• V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
  di: Shasha Jin, et al.
  Pubblicazione: (2024)
• Comparison of efficacy of plasma exchange versus intravenous immunoglobulin as an add‐on therapy in acute attacks of neuromyelitis optica spectrum disorder
  di: Garima Siwach, et al.
  Pubblicazione: (2024)
• External validation of a therapeutic window for risperidone in children with autism spectrum disorder
  di: Rebecca A. Hermans, et al.
  Pubblicazione: (2025)